Interface nationale ANTIBIORÉSISTANCE
Accès Collaboratif privé
Accueil • Veille Scientifique • Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study

A Decrease font size. A Reset font size. A Increase font size.

Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study

The Lancet Infectious Diseases • 2021.04.02

Cohen D., Atsmon J., Artaud C.,
Lire l'article